Nanotechnology Task Force

 

About the Task Force

The FDA Nanotechnology Task Force, formed in August 2006, is charged with determining regulatory approaches that encourage the continued development of innovative, safe, and effective FDA-regulated products that use nanotechnology materials. The Task Force will identify and recommend ways to address any knowledge or policy gaps that exist so as to better enable the agency to evaluate possible adverse health effects from FDA-regulated products that use nanotechnology materials.

Task Force Report - July 2007 [pdf version, 287 KB]

• Press Release
• Fact Sheet
• Consumer Article

FDA Nanotechnology Task Force Press Release (August 9, 2006)

FDA Nanotechnology Task Force Members